Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NNNN

Anbio Biotechnology

May 08 • 10:35AM ET

26.15

+0.27 1.04 %

Healthcare • Medical Instruments & Supplies • Germany • Mid • NASD

May 06, 3:02 PMFears of massive dilution and insider control entrenchment from May 15 shareholder vote pressure Anbio Biotechnology shares.

Peers: ICUI MMSI TFX ITGR HAE

Scroll to Statements

Index	-	P/E	159.74	EPS (ttm)	0.16	Insider Own	9.57%	Shs Outstand	43.89M	Perf Week	-9.52%
Market Cap	3.76B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	39.69M	Perf Month	-2.61%
Enterprise Value	3.75B	PEG	-	EPS next Q	-	Inst Own	0.08%	Short Float	0.13%	Perf Quarter	1.95%
Income	7.19M	P/S	386.32	EPS this Y	-	Inst Trans	-1.82%	Short Ratio	1.26	Perf Half Y	18.86%
Sales	9.74M	P/B	32.41	EPS next Y	-	ROA	26.08%	Short Interest	0.05M	Perf YTD	-13.04%
Book/sh	0.81	P/C	269.15	EPS next 5Y	-	ROE	27.01%	52W High	55.65 -53.01%	Perf Year	294.42%
Cash/sh	0.10	P/FCF	-	EPS past 3/5Y	-12.86% 23.44%	ROIC	20.29%	52W Low	6.34 312.46%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	578.51	Sales past 3/5Y	-26.67% 16.85%	Gross Margin	87.06%	Volatility	10.60% 7.32%	Perf 5Y	-
Dividend TTM	-	EV/Sales	384.88	EPS Y/Y TTM	170.13%	Oper. Margin	66.47%	ATR (14)	2.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	344.31	Sales Y/Y TTM	10.10%	Profit Margin	73.75%	RSI (14)	45.62	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	344.31	EPS Q/Q	321.09%	SMA20	-5.78%	Beta	4.61	Target Price	-
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	87.39%	SMA50	3.24%	Rel Volume	0.38	Prev Close	25.88
Employees	27	LT Debt/Eq	0.00	Earnings	-	SMA200	-16.37%	Avg Volume	41.52K	Price	26.15
IPO	Feb 19, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	3,309	Change	1.04%

Mar-17-26 04:30PM	Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum (GlobeNewswire)
Jan-26-26 01:12PM	Stock Market Today: Trump's Medicare announcement slams health insurers (TheStreet) -24.73%
Aug-08-25 09:05PM	Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System (GlobeNewswire) +10.88% -7.89%
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN) (Insider Monkey) +14.50%
Jul-04-25 06:00AM	The IPO market in 2025 is being driven by a clear theme bigger is better (Yahoo Finance)
01:05AM	Loading…
May-15-25 01:05AM	Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions (GlobeNewswire) +6.12%
Feb-20-25 09:50AM	Anbio Biotechnology Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-18-25 06:10PM	Anbio Biotechnology Announces Pricing of Initial Public Offering (GlobeNewswire)

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NNNN

Anbio Biotechnology

Upgrade your Finviz experience